AU536854B2 - 1 1-dioxopenicillanoyl methyl penicillanate esters - Google Patents

1 1-dioxopenicillanoyl methyl penicillanate esters

Info

Publication number
AU536854B2
AU536854B2 AU13871/83A AU1387183A AU536854B2 AU 536854 B2 AU536854 B2 AU 536854B2 AU 13871/83 A AU13871/83 A AU 13871/83A AU 1387183 A AU1387183 A AU 1387183A AU 536854 B2 AU536854 B2 AU 536854B2
Authority
AU
Australia
Prior art keywords
dioxopenicillanoyl
esters
methyl penicillanate
penicillanate
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU13871/83A
Other languages
English (en)
Other versions
AU1387183A (en
Inventor
Wayne Ernest Barth
Vytautas John Jasys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of AU1387183A publication Critical patent/AU1387183A/en
Application granted granted Critical
Publication of AU536854B2 publication Critical patent/AU536854B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU13871/83A 1982-04-23 1983-04-22 1 1-dioxopenicillanoyl methyl penicillanate esters Expired AU536854B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin
US371156 1999-08-09

Publications (2)

Publication Number Publication Date
AU1387183A AU1387183A (en) 1983-11-17
AU536854B2 true AU536854B2 (en) 1984-05-24

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13871/83A Expired AU536854B2 (en) 1982-04-23 1983-04-22 1 1-dioxopenicillanoyl methyl penicillanate esters

Country Status (27)

Country Link
US (1) US4432987A (enExample)
EP (1) EP0092968B1 (enExample)
JP (1) JPS58201792A (enExample)
KR (1) KR860001279B1 (enExample)
AU (1) AU536854B2 (enExample)
CA (1) CA1187484A (enExample)
CS (1) CS235320B2 (enExample)
DD (1) DD209632A5 (enExample)
DE (1) DE3362502D1 (enExample)
DK (1) DK162168C (enExample)
EG (1) EG16412A (enExample)
ES (1) ES521728A0 (enExample)
FI (1) FI76092C (enExample)
GR (1) GR78582B (enExample)
HK (1) HK20588A (enExample)
HU (1) HU187068B (enExample)
IE (1) IE54628B1 (enExample)
IL (1) IL68453A (enExample)
NO (1) NO156202C (enExample)
NZ (1) NZ203988A (enExample)
PH (1) PH18035A (enExample)
PL (1) PL134978B1 (enExample)
PT (1) PT76587B (enExample)
SG (1) SG104087G (enExample)
SU (1) SU1138030A3 (enExample)
YU (1) YU43170B (enExample)
ZA (1) ZA832845B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
EP0247156B1 (en) * 1985-11-18 1993-06-23 Access Pharmaceuticals Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
US6111098A (en) * 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
EP1535907A4 (en) 2002-08-29 2006-11-29 Taisho Pharmaceutical Co Ltd BENZOLSULFONATE OF A 4-FLUORO-2-CYANOPYRROLIDINE DERIVATIVE
PL1606293T3 (pl) * 2003-03-27 2010-01-29 Basilea Pharmaceutica Ag Cefalosporyna w postaci krystalicznej
BRPI0416138A (pt) * 2003-10-31 2007-01-02 Alza Corp composições e formas de dosagem para a absorção realçada de gabapentina e pregabalina
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
PL2195293T3 (pl) 2007-08-22 2014-03-31 Astrazeneca Ab Pochodne cyklopropyloamidu
EP2620432A3 (en) 2007-10-26 2013-12-18 The Regents Of the University of California Diarylhydantoin compounds
EA018907B1 (ru) * 2009-01-30 2013-11-29 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Кристаллический гидрохлорид n-{(1s)-2-амино-1-[(3-фторфенил)метил]этил}-5-хлор-4-(4-хлор-1-метил-1h-пиразол-5-ил)-2-тиофенкарбоксамида
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
CA2767785A1 (en) * 2009-07-10 2011-01-13 Evolva Ag Diyne compositions
WO2011102795A1 (en) * 2010-02-18 2011-08-25 Astrazeneca Ab New crystalline form of a cyclopropyl benzamide derivative
EP2536701A4 (en) * 2010-02-18 2014-05-07 Astrazeneca Ab SOLID FORMS WITH A CYCLOPROPYLAMID DERIVATIVE
US9518004B2 (en) * 2012-12-03 2016-12-13 Kaneka Corporation Reduced coenzyme Q10 derivative and method for production thereof
KR20160051833A (ko) * 2013-09-05 2016-05-11 미쓰비시 타나베 파마 코퍼레이션 신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법
EA035145B1 (ru) 2014-10-21 2020-05-06 Ариад Фармасьютикалз, Инк. Кристаллические формы 5-хлор-n4-[2-(диметилфосфорил)фенил]-n2-{2-метокси-4-[4-(4-метилпиперазин-1-ил)пиперидин-1-ил]фенил}пиримидин-2,4-диамина
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
JP7046815B2 (ja) * 2016-01-22 2022-04-04 サンド・アクチエンゲゼルシヤフト 結晶質エラバサイクリンビス塩酸塩
JP2019524710A (ja) 2016-07-07 2019-09-05 アイアンウッド ファーマシューティカルズ インコーポレイテッド Ｓｇｃ刺激剤の固体形態
EP3703686A4 (en) * 2017-10-30 2021-11-17 Theracaine LLC HYDROPHOBIC ARENE SULFONATE SALTS
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
USD998740S1 (en) 2019-02-13 2023-09-12 Hs Produkt D.O.O. Firearm
USD994821S1 (en) 2019-02-13 2023-08-08 Hs Produkt D.O.O. Pistol
USD1071069S1 (en) 2019-02-13 2025-04-15 Hs Produkt D.O.O. Stippled textured body for a firearm or the like
USD1077123S1 (en) 2019-02-13 2025-05-27 Hs Produkt D.O.O. Firearm sight
USD1057880S1 (en) 2019-08-09 2025-01-14 Hs Produkt D.O.O. Pistol
EP4291159A1 (en) * 2021-02-15 2023-12-20 Propella Therapeutics, Inc. Abiraterone prodrugs
USD1049292S1 (en) * 2021-04-06 2024-10-29 Springfield, Inc. Pistol
CA3219786A1 (en) * 2021-05-14 2022-11-17 Global Blood Therapeutics, Inc. Solid forms of a modulator of hemoglobin
USD1069964S1 (en) 2021-11-03 2025-04-08 Hs Produkt D.O.O. Pistol slide
JP2024546191A (ja) * 2021-12-28 2024-12-17 深▲セン▼揚歴医薬技術有限公司 テトラヒドロシクロヘプタインダゾール化合物の塩形、結晶
USD1057882S1 (en) 2022-08-29 2025-01-14 Springfield, Inc. Combined serrations for a firearm slide
USD1072997S1 (en) 2022-08-29 2025-04-29 Springfield, Inc. Firearm
USD1061781S1 (en) 2022-11-30 2025-02-11 Hs Produkt D.O.O. Pistol
ZAA202301172S (en) 2023-04-28 2024-06-26 Hs Produkt D O O Firearm
TW202517651A (zh) * 2023-07-17 2025-05-01 美商庫拉腫瘤技術股份有限公司 Menin抑制劑之晶型

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
BE881675A (fr) * 1979-02-13 1980-08-12 Leo Pharm Prod Ltd B-lactames derives de l'acide penicillanique leur preparation et leurs utilisations therapeutiques
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI831392A0 (fi) 1983-04-22
PL134978B1 (en) 1985-09-30
SU1138030A3 (ru) 1985-01-30
SG104087G (en) 1988-07-15
KR860001279B1 (ko) 1986-09-05
AU1387183A (en) 1983-11-17
US4432987A (en) 1984-02-21
CS235320B2 (en) 1985-05-15
IL68453A (en) 1986-08-31
PT76587B (en) 1986-02-27
IE830926L (en) 1983-10-23
PH18035A (en) 1985-03-06
EP0092968B1 (en) 1986-03-12
GR78582B (enExample) 1984-09-27
FI76092C (fi) 1988-09-09
DK162168C (da) 1992-03-02
HK20588A (en) 1988-03-25
ZA832845B (en) 1984-11-28
FI76092B (fi) 1988-05-31
ES8406075A1 (es) 1984-07-01
JPS58201792A (ja) 1983-11-24
ES521728A0 (es) 1984-07-01
DK101783D0 (da) 1983-02-28
YU90483A (en) 1986-04-30
EP0092968A1 (en) 1983-11-02
DK162168B (da) 1991-09-23
EG16412A (en) 1989-03-30
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
YU43170B (en) 1989-04-30
PT76587A (en) 1983-05-01
DD209632A5 (de) 1984-05-16
NO156202B (no) 1987-05-04
HU187068B (en) 1985-11-28
KR840004437A (ko) 1984-10-15
FI831392L (fi) 1983-10-24
JPH0119395B2 (enExample) 1989-04-11
DE3362502D1 (en) 1986-04-17
IL68453A0 (en) 1983-07-31
CA1187484A (en) 1985-05-21
IE54628B1 (en) 1989-12-20
NO156202C (no) 1987-08-19
DK101783A (da) 1983-10-24
PL241553A1 (en) 1983-11-21

Similar Documents

Publication Publication Date Title
AU536854B2 (en) 1 1-dioxopenicillanoyl methyl penicillanate esters
AU543861B2 (en) Oltahydro-1h-indole-2-carboxylic acids
GB8326029D0 (en) Esters
GB8320518D0 (en) Cefuroxime ester
DE3361480D1 (en) Difluoromethoxyphenylthiophosphoric-acid esters
AU7702281A (en) 1-carboxy-azaalkanoylindoline-2-carboxylic acids
AU558627B2 (en) 2-oxo-1-azetidinesulphonic acids derivatives
AU2098183A (en) Atomizer
AU545463B2 (en) Benzoyl piperacine esters
AU564022B2 (en) Biotin esters
AU553322B2 (en) 3-methyl-flavone-8-carboxylic acid esters
AU7192981A (en) N-acylated-n-methyl-carbamic acid-0-pyrazol-4-yl esters
AU538789B2 (en) 3-azidomethyl penicillin
AU537625B2 (en) Aryl-cyclopropane esters
AU535417B2 (en) Penicillanic acid esters
AU2138783A (en) Penicillins
MY8700194A (en) Carbamic-acid esters
AU558708B2 (en) 6-bromo-3-chloromethyl-3-methyl-penam-2-carboxylic acids
AU547381B2 (en) Penicillin derivative
AU559689B2 (en) Penicillin derivative
GB2156351B (en) An ester
AU1308883A (en) Penicillins
AU8440782A (en) Playing set
JPS57169461A (en) Phenoxypyridylmethyl esters
AU2253483A (en) Atomizer

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired